• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性早幼粒细胞白血病的小鼠模型

Mouse models of acute promyelocytic leukemia.

作者信息

Kogan S C

机构信息

Department of Laboratory Medicine and Comprehensive Cancer Center, University of California, San Francisco, Room S-864, 513 Parnassus Avenue, San Francisco, CA 94143-0100, USA.

出版信息

Curr Top Microbiol Immunol. 2007;313:3-29. doi: 10.1007/978-3-540-34594-7_2.

DOI:10.1007/978-3-540-34594-7_2
PMID:17217036
Abstract

Mouse models of acute promyelocytic leukemia have been generated through transgenic, knock-in, retroviral, and xenograft strategies. These models have been used to elucidate mechanisms underlying leukemogenesis. Among the areas investigated are the role of reciprocal fusions; effects of target cells, expression levels, and mouse strains; cooperating events; and restrictive and permissive factors. These models have also been used to gain insight into the effects of the immune system on leukemic cells and the mechanism of response to retinoic acid. Furthermore, preclinical studies utilizing these mice have advanced therapy for myeloid leukemia.

摘要

急性早幼粒细胞白血病的小鼠模型已通过转基因、基因敲入、逆转录病毒和异种移植策略构建出来。这些模型已被用于阐明白血病发生的潜在机制。研究领域包括相互融合的作用;靶细胞、表达水平和小鼠品系的影响;协同事件;以及限制性和许可性因素。这些模型还被用于深入了解免疫系统对白血病细胞的影响以及对维甲酸反应的机制。此外,利用这些小鼠进行的临床前研究推动了髓系白血病的治疗进展。

相似文献

1
Mouse models of acute promyelocytic leukemia.急性早幼粒细胞白血病的小鼠模型
Curr Top Microbiol Immunol. 2007;313:3-29. doi: 10.1007/978-3-540-34594-7_2.
2
In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications.小鼠急性早幼粒细胞白血病分子发病机制的体内分析及其治疗意义。
Oncogene. 1999 Sep 20;18(38):5278-92. doi: 10.1038/sj.onc.1203088.
3
Therapeutic efficacy of NSC606985, a novel camptothecin analog, in a mouse model of acute promyelocytic leukemia.新型喜树碱类似物NSC606985在急性早幼粒细胞白血病小鼠模型中的治疗效果
Leuk Res. 2007 Nov;31(11):1565-74. doi: 10.1016/j.leukres.2007.03.011. Epub 2007 Apr 10.
4
A PMLRARalpha transgene initiates murine acute promyelocytic leukemia.PML-RARα转基因引发小鼠急性早幼粒细胞白血病。
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2551-6. doi: 10.1073/pnas.94.6.2551.
5
Histone modifications patterns in tissues and tumours from acute promyelocytic leukemia xenograft model in response to combined epigenetic therapy.急性早幼粒细胞白血病异种移植模型的组织和肿瘤中组蛋白修饰模式对联合表观遗传治疗的反应
Biomed Pharmacother. 2016 Apr;79:62-70. doi: 10.1016/j.biopha.2016.01.044. Epub 2016 Feb 16.
6
Retinoic acid receptors, hematopoiesis and leukemogenesis.维甲酸受体、造血作用与白血病发生
Curr Opin Hematol. 2008 Jul;15(4):346-51. doi: 10.1097/MOH.0b013e3283007edf.
7
Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.在急性早幼粒细胞白血病(APL)转基因模型中,视黄酸(RA)和三氧化二砷(As2O3)治疗揭示了由PML-RARα和PLZF-RARα癌蛋白诱导的白血病发生过程的独特性质。
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10173-8. doi: 10.1073/pnas.180290497.
8
Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.三氧化二砷治疗复发的全反式维甲酸耐药急性早幼粒细胞白血病所致的维甲酸综合征
Leuk Lymphoma. 2000 Jun;38(1-2):195-8. doi: 10.3109/10428190009060334.
9
APL as a paradigm in biomedical research: a journey toward the cure.急性早幼粒细胞白血病作为生物医学研究中的一种范式:走向治愈的历程。
Curr Top Microbiol Immunol. 2007;313:1-2. doi: 10.1007/978-3-540-34594-7_1.
10
Extramedullary disease in acute promyelocytic leukemia.急性早幼粒细胞白血病中的髓外疾病
Leuk Lymphoma. 1999 Apr;33(3-4):219-29. doi: 10.3109/10428199909058422.

引用本文的文献

1
History of Developing Acute Promyelocytic Leukemia Treatment and Role of Promyelocytic Leukemia Bodies.急性早幼粒细胞白血病治疗的发展历程及早幼粒细胞白血病小体的作用
Cancers (Basel). 2024 Mar 29;16(7):1351. doi: 10.3390/cancers16071351.
2
Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia.急性早幼粒细胞白血病:60 多年的历程——从最恶性的急性白血病形式到最可治愈的形式
Oncol Ther. 2019 Jun;7(1):33-65. doi: 10.1007/s40487-018-0091-5. Epub 2019 Feb 5.
3
Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies.
急性早幼粒细胞白血病:白血病发生、耐药机制及创新治疗策略的最新进展
Cancers (Basel). 2019 Oct 18;11(10):1591. doi: 10.3390/cancers11101591.
4
RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin-proteasome pathway contributes to the reversion of ATRA resistance.RNF8在具有GTF2I/RARA融合的变异型急性早幼粒细胞白血病中导致全反式维甲酸(ATRA)耐药,而抑制泛素-蛋白酶体途径有助于逆转ATRA耐药。
Cancer Cell Int. 2019 Apr 4;19:84. doi: 10.1186/s12935-019-0803-4. eCollection 2019.
5
PML-RARA-associated cooperating mutations belong to a transcriptional network that is deregulated in myeloid leukemias.PML-RARA 相关的合作突变属于一个转录网络,该网络在髓系白血病中失调。
Leukemia. 2017 Sep;31(9):1975-1986. doi: 10.1038/leu.2016.386. Epub 2016 Dec 27.
6
From molecular interaction to acute promyelocytic leukemia: Calculating leukemogenesis and remission from endogenous molecular-cellular network.从分子相互作用到急性早幼粒细胞白血病:基于内源性分子-细胞网络计算白血病发生及缓解情况
Sci Rep. 2016 Apr 21;6:24307. doi: 10.1038/srep24307.
7
PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.早幼粒细胞白血病-维甲酸受体α融合蛋白需要DNA甲基转移酶3A来引发急性早幼粒细胞白血病。
J Clin Invest. 2016 Jan;126(1):85-98. doi: 10.1172/JCI82897. Epub 2015 Nov 23.
8
Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADD.外源性凋亡因APL融合蛋白NPM-RAR与TRADD的直接结合而受到阻碍。
Mol Cancer Res. 2014 Sep;12(9):1283-91. doi: 10.1158/1541-7786.MCR-14-0080. Epub 2014 Jul 17.
9
Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA mice.Ctsg-PML-RARA 小鼠造血祖细胞中 PML-RARA 的表达和功能。
PLoS One. 2012;7(10):e46529. doi: 10.1371/journal.pone.0046529. Epub 2012 Oct 8.
10
The origin and evolution of mutations in acute myeloid leukemia.急性髓细胞白血病突变的起源和演变。
Cell. 2012 Jul 20;150(2):264-78. doi: 10.1016/j.cell.2012.06.023.